{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:04:13Z","timestamp":1789790653002,"version":"4.0.1"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,9,15]]},"DOI":"10.2169\/internalmedicine.6582-25","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:10:56Z","timestamp":1770675056000},"page":"2471-2476","source":"Crossref","is-referenced-by-count":0,"title":["Incidental &lt;i&gt;MSH6&lt;\/i&gt; Germline Pathogenic Variant Identified through Tumor-only Comprehensive Genomic Profiling in a Patient with Small Cell Lung Cancer"],"prefix":"10.2169","volume":"65","author":[{"given":"Hideto","family":"Ishimoto","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikako","family":"Miyata","sequence":"additional","affiliation":[{"name":"Cancer Genomics Center, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyomi","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Cancer Genomics Center, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Koike","sequence":"additional","affiliation":[{"name":"Cancer Genomics Center, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeko","family":"Nakatsubo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Adachi","sequence":"additional","affiliation":[{"name":"Cancer Genomics Center, Toyonaka Municipal Hospital, Japan"},{"name":"Department of Pathology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Nishida","sequence":"additional","affiliation":[{"name":"Cancer Genomics Center, Toyonaka Municipal Hospital, Japan"},{"name":"Department of Gastroenterology, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Tomita","sequence":"additional","affiliation":[{"name":"Cancer Genomics Center, Toyonaka Municipal Hospital, Japan"},{"name":"Department of Gastroenterological Surgery, Toyonaka Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yamaguchi M, Akabane S, Niitsu H, et al. The usefulness of comprehensive genome profiling test in screening of Lynch syndrome independent of the conventional clinical screening or microsatellite instability tests. J Hum Genet 70: 385-393, 2025.","DOI":"10.1038\/s10038-025-01345-x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Jaber D, Zhang J, Godley LA. Detecting likely germline variants during tumor-based molecular profiling. J Clin Invest 135: 2025.","DOI":"10.1172\/JCI190264"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Peltomaki P, Nystrom M, Mecklin JP, Seppala TT. Lynch syndrome genetics and clinical implications. Gastroenterology 164: 783-799, 2023.","DOI":"10.1053\/j.gastro.2022.08.058"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Plaschke J, Engel C, Kr\u00fcger S, et al. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic <i>MSH6<\/i> germline mutations compared with families with <i>MLH1<\/i> or <i>MSH2<\/i> mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 22: 4486-4494, 2004.","DOI":"10.1200\/JCO.2004.02.033"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nishida T, Miyamoto M, Yasuda J, et al. Awareness and implementation of comprehensive genomic profiling and cancer support for adolescents and young adults among healthcare professionals in Osaka, Japan. Jpn J Clin Oncol 55: 246-252, 2025.","DOI":"10.1093\/jjco\/hyae159"},{"key":"6","unstructured":"6. Dominguez-Valentin M, Sampson JR, Seppala TT, et al. Cancer risks by gene, age, and gender in 6,350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med 22: 15-25, 2020."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pallatt S, Nambidi S, Adhikary S, Banerjee A, Pathak S, Duttaroy AK. A brief review of Lynch syndrome: understanding the dual cancer risk between endometrial and colorectal cancer. Oncol Rev 19: 1549416, 2025.","DOI":"10.3389\/or.2025.1549416"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ryan NAJ, Morris J, Green K, et al. Association of mismatch repair mutation with age at cancer onset in Lynch syndrome: implications for stratified surveillance strategies. JAMA Oncol 3: 1702-1706, 2017.","DOI":"10.1001\/jamaoncol.2017.0619"},{"key":"9","unstructured":"9. The Editorial Board of the Cancer Statistics in Japan. Cancer Statistics in Japan 2022. Foundation for Promotion of Cancer Research, Tokyo, 2022."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Barrow E, Robinson L, Alduaij W, et al. Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet 75: 141-149, 2009.","DOI":"10.1111\/j.1399-0004.2008.01125.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Han Q, Liu S, Cui Z, et al. Case report and literature review: diagnosis, tailored genetic counseling and cancer prevention for a locally advanced dMMR\/MSI-H\/TMB-H lung cancer patient with concurrent Lynch syndrome mediated by a rare <i>PMS2<\/i> splicing variant (c.1144+1G&gt;A). Front Genet 12: 799807, 2021.","DOI":"10.3389\/fgene.2021.799807"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Canney A, Sheahan K, Keegan D, Tolan M, Hyland J, Green A. Synchronous lung tumours in a patient with metachronous colorectal carcinoma and a germline MSH2 mutation. J Clin Pathol 62: 471-473, 2009.","DOI":"10.1136\/jcp.2008.063008"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Werf-&apos;t Lam AV, Dowty JG, Italia M, et al. Cancer risks for MSH6 pathogenic variant carriers. Eur J Cancer 231: 116098, 2025.","DOI":"10.1016\/j.ejca.2025.116098"},{"key":"14","unstructured":"14. Le DT, Durham JN, Smith KN, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357: 409-413, 2017."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/18\/65_6582-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:31:32Z","timestamp":1789788692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/18\/65_6582-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":14,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6582-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"6582-25"}}